On February 09, 2022, Bone Biologics Corp. (BBLG) stock added a good 19.59% during regular trading. The stock continued to rise in the after-hours to gain a further 7.85%. No official announcement or SEC filing is responsible for the bullish momentum of the stock.
The medical device company’s stock had a value of $2.5592 per share at the close of the previous regular trading session. After adding a further $0.20 in the after-hours, BBLG stock reached a value of $2.7600 per share, on Wednesday.
Founded in 2004, Bone Biologics Corp. has a market capitalization of $22.15 million. Currently, the company has 10.5 million shares outstanding in the market.
BBLG stock Movement
BBLG stock has been in an uptrend since Monday, thus marking today as the third consecutive day of its bullishness. There is no official announcement or SEC filing from the company to explain the bullish momentum. It seems the stock has been gaining on external factors like social media discussions and stock sentiment.
The recent bullish momentum has led the stock to gain a good 21.87% in the past five days. Presently, BBLG stands at a yea to date loss of 27.30% while it declined by a huge 86.35% last year.
Recent Participation
Recently, the company participated in the H.C. Wainwright BioConnect Virtual Conference. BBLG’s president and chief executive officer, Jeffrey Frelick presented at the conference on January 10. The conference took place from January 10 to January 13, 2022.
BBLG’s SEC Filings
8-K Current Report
On December 22, the company filed a current report on Form 8-K regarding the employment agreement of its CFO, Deina H. Walsh. As per the revised employment agreement, her employment with the company was changed from a specified period to at-will. Furthermore, the agreement stated her base salary as $200,000 with eligibility for an annual bonus of 25% of the base salary.
Ms. Walsh has been serving as BBLG’s Chief Financial Officer since November 4, 2014.
10-Q Quarterly Report
On November 15, the company filed its financial results for the third quarter of 2021.
In the third quarter of 2021, the company had a net loss of $509.3K against $394.0K in the year-ago quarter. Resultantly, the net loss per basic and diluted share was $0.17 and $0.14 in Q3 2021 and 2020, respectively.
Moreover, BBLG had no revenues in the third quarter of 2021.
Public Offering
On October 18, the company announced the closing of its public offering of 1,510,455 securities units at $5.25 per unit. The total gross proceeds from the offering were $7.9 million less discounts and commissions.
